MedPath
HSA Approval

DORZOLAMIDE AND TIMOLOL STADA EYE DROPS 20MG/5MG

SIN14556P

DORZOLAMIDE AND TIMOLOL STADA EYE DROPS 20MG/5MG

DORZOLAMIDE AND TIMOLOL STADA EYE DROPS 20MG/5MG

June 3, 2014

DCH AURIGA SINGAPORE

DCH AURIGA SINGAPORE

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantDCH AURIGA SINGAPORE
Licence HolderDCH AURIGA SINGAPORE

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

SOLUTION, STERILE

OPHTHALMIC

Medical Information

S01ED51

timolol, combinations

Manufacturer Information

DCH AURIGA SINGAPORE

Famar S.A.

Active Ingredients

Timolol maleate 6.83mg equivalent to Timolol

5mg/ml

Timolol

Dorzolamide hydrochloride 22.26mg equivalent to Dorzolamide

20mg/ml

Dorzolamide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DORZOLAMIDE AND TIMOLOL STADA EYE DROPS 20MG/5MG - HSA Approval | MedPath